A Clinical Study of MR13A9 in Hemodialysis Patients With Pruritus.

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04728984` - A Multi-site Bridging Study of Nalfurafine Hydrochloride Orally Disintegrating Tablet	Phase 3
Completed	`NCT02143973` - Open Label Extension Study of Nalbuphine HCl ER in Hemodialysis Patients With Uremic Pruritus	Phase 2/Phase 3
Terminated	`NCT01660243` - Efficacy and Safety of MT-9938 for Treatment of Uremic Pruritus in Subjects With End-stage Renal Disease Receiving Hemodialysis	Phase 2
Completed	`NCT06159686` - The Efficacy of Hemp-containing Cream Versus Placebo in the Treatment of Uremic Pruritus	Phase 1/Phase 2
Not yet recruiting	`NCT05525234` - A Study of Thalidomide in the Treatment of Refractory Uremic Pruritus	Phase 4
Completed	`NCT03002233` - TRK-820 Study in Subjects on Hemodialysis With or Without Uremic Pruritus	Phase 1
Completed	`NCT03998163` - CR845-CLIN3105: A Study to Evaluate the Safety and Effectiveness of CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus	Phase 3
Active, not recruiting	`NCT05885737` - Phase 3 Study of Difelikefalin in Haemodialysis Chinese Adult Subjects With Moderate-to-Severe Pruritus	Phase 3
Recruiting	`NCT04393675` - Study to Investigate the Safety of LT5001 Drug Product for Uremic Pruritus in Hemodialysis Patients	Phase 1/Phase 2
Completed	`NCT03576235` - Safety and Efficacy of PG102P for Uremic Pruritus in HD Patients	N/A
Completed	`NCT05575193` - Acupressure on Uremic Pruritus and Sleep Quality Among Patients Receiving Hemodialysis	N/A
Completed	`NCT02858726` - Study to Evaluate IV CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus	Phase 2/Phase 3
Completed	`NCT02143648` - Study of Nalbuphine HCl ER Tablets in Hemodialysis Patients With Uremic Pruritus	Phase 2/Phase 3
Completed	`NCT00494975` - The Effect of Phototherapy on Pruritus of Patients With Chronic Kidney Disease	N/A
Recruiting	`NCT06446310` - Phase 3 Study of QLG2198 in Haemodialysis Chinese Adult Subjects With Moderate-to-Severe Pruritus	Phase 3
Completed	`NCT03758079` - Comparison of Gabapentin With Doxepin in the Management of Uremic Pruritus	Phase 4
Completed	`NCT02229929` - Safety and Pharmacokinetics of IV CR845 in Hemodialysis Patients, and Its Efficacy in Patients With Uremic Pruritus	Phase 2
Completed	`NCT04639674` - AST-120 in Hemodialysis Patients With Uremic Pruritus	Phase 4
Completed	`NCT03636269` - CR845-CLIN3103: A Global Study to Evaluate the Safety and Efficacy of CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus	Phase 3
Not yet recruiting	`NCT06466421` - Fexofenadine Versus Gabapentin for Uremic Pruritus in Patients on Regular Hemodialysis	Phase 4

NCT number	NCT03802617
Study type	Interventional
Source	Kissei Pharmaceutical Co., Ltd.
Contact
Status	Completed
Phase	Phase 2
Start date	February 1, 2019
Completion date	October 22, 2019

A Clinical Study of MR13A9 in Hemodialysis Patients With Pruritus.

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms